Aleksandra Winiarska Selected Research

caspase-activated DNase inhibitor

1/2018

Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts disease-free and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aleksandra Winiarska Research Topics

Disease

1	Burns 02/2022
1	Hypothermia 02/2022
1	Wound Infection (Wound Infections) 02/2022
1	Wounds and Injuries (Trauma) 02/2022
1	Breast Neoplasms (Breast Cancer) 04/2021
1	Neoplasms (Cancer) 04/2021
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Type I Syndactyly 01/2019
1	Endometrial Neoplasms (Endometrial Cancer) 01/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2018

Drug/Important Bio-Agent (IBA)

1	HydrogelsIBA 02/2022
1	Hormones (Hormone)IBA 04/2021
1	Phenobarbital (Luminal)FDA Link 04/2021
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 04/2021
1	histidine-rich proteinsIBA 01/2019
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2019
1	caspase-activated DNase inhibitorIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018

Therapy/Procedure

1	First Aid (Aids, First) 02/2022